ロード中...
Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation
Activation of the epidermal growth factor receptor (EGFR) pathway plays an important role in the progression of cancer and is associated with a poor prognosis in patients. The monoclonal antibody cetuximab, which displays EGFR extracellular domain-specific binding, has proven effective in the treatm...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6826992/ https://ncbi.nlm.nih.gov/pubmed/31615015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101552 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|